成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 5382-17-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5382-17-2
Chemical Structure| 5382-17-2
Structure of 5382-17-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 5382-17-2 ]

Related Doc. of [ 5382-17-2 ]

Alternatived Products of [ 5382-17-2 ]
Product Citations

Product Details of [ 5382-17-2 ]

CAS No. :5382-17-2 MDL No. :MFCD00035298
Formula : C5H12ClNO Boiling Point : No data available
Linear Structure Formula :- InChI Key :VKCORPXOKYDINR-UHFFFAOYSA-N
M.W : 137.61 Pubchem ID :16212499
Synonyms :

Calculated chemistry of [ 5382-17-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 38.88
TPSA : 32.26 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.47
Log Po/w (WLOGP) : 0.15
Log Po/w (MLOGP) : 0.21
Log Po/w (SILICOS-IT) : 0.73
Consensus Log Po/w : 0.31

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.99
Solubility : 14.1 mg/ml ; 0.103 mol/l
Class : Very soluble
Log S (Ali) : -0.72
Solubility : 26.4 mg/ml ; 0.192 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.44
Solubility : 50.3 mg/ml ; 0.366 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 5382-17-2 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 5382-17-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 5382-17-2 ]

[ 5382-17-2 ] Synthesis Path-Downstream   1~20

  • 1
  • [ 151-50-8 ]
  • [ 108-94-1 ]
  • [ 5382-17-2 ]
  • [ 60756-86-7 ]
  • 2
  • [ 5382-17-2 ]
  • [ 814-68-6 ]
  • 1-(4-hydroxypiperidine)prop-2-en-1-one [ No CAS ]
  • 3
  • [ 13734-34-4 ]
  • [ 5382-17-2 ]
  • [ 186431-51-6 ]
  • 4
  • [ 5382-17-2 ]
  • [ 41153-30-4 ]
  • [ 186431-68-5 ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In DMF (N,N-dimethyl-formamide); at 20℃; for 16.0h; To a stirred solution OF BOC-3- (4-FLUOROPHENYL)- (S)-ALANINE (LO. OG, 35. 3MMOL), <strong>[5382-17-2]4-hydroxypiperidine hydrochloride</strong> (5. 1G, 37. 1MMOL) and HOBt (7.2g, 52. 9MMOL) in DMF (lOOmL), was added DIPEA (12. 3mL, 70. 6MMOL) and after 5MIN, EDCI (7.4g, 38. 8MMOL) and the reaction stirred at rt for 16H. The solvent was removed in vacuo and the residue partitioned between water (150ML) and ethyl acetate (2 x 150ML). The combined organic fractions were washed with sodium hydroxide solution (2M, 50ML), hydrochloric acid (2N, 50ML), dried (MGS04) and concentrated in vacuo. The product was chromatographed on silica gel eluting with ethyl acetate to give the title compound as a white solid. m/z (ES+) = 367 [M+ H] + ; RT = 3.28min.
  • 5
  • [ 13414-95-4 ]
  • [ 5382-17-2 ]
  • 1-(4,5,6,7-Tetrahydro-benzo[b]thiophen-4-yl)-piperidin-4-ol [ No CAS ]
  • 6
  • [ 5382-17-2 ]
  • [1-chloro-4-(3-chloro-4-methoxybenzyl)amino]-6-[4-14C]phthalazinecarbonitrile [ No CAS ]
  • C21(14)CH22ClN5O2 [ No CAS ]
  • 7
  • [ 24424-99-5 ]
  • [ 5382-17-2 ]
  • [ 109384-19-2 ]
  • 8
  • [ 506-68-3 ]
  • [ 5382-17-2 ]
  • [ 51075-37-7 ]
YieldReaction ConditionsOperation in experiment
With sodium carbonate; In dichloromethane; water; at 0℃; for 1.08333h; Preparation 11: 4-Hydroxypiperidine-l-carbonitrileA stirred slurry OfNa2CO3 (9.8 g, 117 mmol) in water (15 mL) was cooled on ice-water and 4-hydroxypiperidine.HCl (4.0 g, 29.2 mmol) was added. A solution of cyanogen bromide(3.7 g, 35 mmol) in CH2Cl2 (90 mL) was added portionwise over 5 min and the stirring continued for 1 h. The reaction was diluted with CH2Cl2 ( 100 mL), the organic phase separated and dried (MgSO-O and the solvent evaporated to afford the title cyanamide: SH (CDCl3) 1.65 (ddt, 2H), 1.91 (ddt, 2H), 2.17 (br s, IH), 3.08 (ddd, 2H), 3.45 (ddd, 2H), 3.86 (sept, IH).
  • 9
  • [ 5198-49-2 ]
  • [ 5382-17-2 ]
  • 1-[2-(4-chlorophenylamino)ethyl]piperidin-4-ol [ No CAS ]
  • 10
  • [ 5382-17-2 ]
  • [ 73775-92-5 ]
  • 11
  • [ 5382-17-2 ]
  • N-[18F]Fluoroethyl-4-piperidyl acetate [ No CAS ]
  • 12
  • [ 5382-17-2 ]
  • [ 850452-53-8 ]
  • 13
  • [ 5382-17-2 ]
  • 5-Chloro-1H-indole-2-carboxylic acid [(1S)-benzyl-2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-amide [ No CAS ]
  • 14
  • [ 5382-17-2 ]
  • 5-chloro-1H-indole-2-carboxylic acid [(1S)-(4-fluoro-benzyl)-2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-amide [ No CAS ]
  • 15
  • [ 5382-17-2 ]
  • (S)-2-Amino-1-(4-hydroxy-piperidin-1-yl)-3-phenyl-propan-1-one hydrochloride [ No CAS ]
  • 16
  • [ 5382-17-2 ]
  • (S)-2-Amino-3-(4-fluoro-phenyl)-1-(4-hydroxy-piperidin-1-yl)-propan-1-one hydrochloride [ No CAS ]
  • 17
  • [ 5382-17-2 ]
  • [ 60232-85-1 ]
  • 18
  • [ 52273-55-9 ]
  • [ 5382-17-2 ]
  • [ 841200-90-6 ]
YieldReaction ConditionsOperation in experiment
90% With N-ethyl-N,N-diisopropylamine; In acetonitrile; at 60℃; for 18.0h; A solution of 4-(3-bromo-propyl)-phenol (EXAMPLE 6; 1.42 g, 6.6 mmol), <strong>[5382-17-2]4-hydroxypiperidine hydrochloride</strong> (908 mg, 6.6 mmol), and N,N-diisopropylethyamine (2.2 mL, 12.3 mmol) in CH3CN (20 mL) was stirred at 60° C. for 18 h. The reaction mixture was cooled to room temperature, and the solvent was removed under reduced pressure to yield an off-white solid. This material was dissolved in CH2Cl2 (200 mL), and the solution was washed with H2O (2.x.50 mL), dried (Na2SO4), filtered and concentrated under reduce pressure to yield a white solid. Diethyl ether was added, and the title compound was collected by filtration (1.4 g, 90percent yield). TLC (SiO2, 5percent 2 M NH3 in CH3OH/CH2Cl2): Rf=0.05. MS (ESI): mass calculated for C14H21NO2, 235.16; m/z found, 236.2 [M+H]+. 1H NMR (400 MHz, CD3OD): 6.96-6.94 (m, 2H), 6.64-6.61 (m, 2H), 3.89-3.82 (m, 1H), 3.29-3.20 (m, 4H), 3.02-2.95 (m, 4H), 2.52 (t, J=7.4, 2H), 1.95-1.87 (m, 4H), 1.68-1.60 (m, 2H).
90% With N-ethyl-N,N-diisopropylamine; In acetonitrile; at 60℃; for 18.0h; EXAMPLE 36; 1- {3- [4- (BENZOOXAZOL-2-YLOXY)-PHENYL]-PROPYL}-PIPERIDIN-4-OL; A. 1-F3- 4-HVDROXV-PHENYL)-PROPY]-PIPERIDIN-4-OL; A SOLUTION of 4- (3-bromo- propyl)-phenol (EXAMPLE 6; 1.42 g, 6.6 MMOL), <strong>[5382-17-2]4-hydroxypiperidine hydrochloride</strong> (908 mg, 6.6 mmol), and N, N-diisopropylethyamine (2.2 mL, 12.3 MMOL) in CH3CN (20 mL) was stirred at 60 °C for 18 h. The reaction mixture was cooled to room temperature, and the solvent was removed under reduced pressure to yield an off-white solid. This material was dissolved in CH2CI2 (200 mL), and the solution was washed with H20 (2 x 50 mL), dried (Na2SO4), filtered and concentrated under reduce pressure to yield a white solid. Diethyl ether was added, and the title compound was collected by filtration (1.4 g, 90percent yield). TLC(SiO2, 5percent 2 M NH3 in CH3OH/CH2Cl2) : Rf = 0. 05. MS (ESI) : mass calculated for C14H21NO2, 235.16 ; m/z found, 236.2 [M+H] +. H NMR (400 MHz, CD30D) : 6.96-6. 94 (m, 2H), 6.64-6. 61 (m, 2H), 3.89-3. 82 (m, 1 H), 3.29- 3.20 (m, 4H), 3.02-2. 95 (m, 4H), 2.52 (t, J = 7.4, 2H), 1.95-1. 87 {M, 4H), 1.68- 1.60 (m, 2H)
  • 19
  • C17H17ClF6N2O [ No CAS ]
  • [ 5382-17-2 ]
  • (2S)-N-[3,5-bis(trifluoromethyl)benzyl]-1-[2-(4-hydroxypiperidin-1-yl)ethyl]-2,5-dihydro-1H-pyrrole-2-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium hydrogencarbonate; In ethanol; water; at 80℃; for 5.0h; 150 mg of the above chloroethylaminoamide, 400 mg of <strong>[5382-17-2]4-hydroxypiperidine hydrochloride</strong> and 800 mg of sodium bicarbonate in 5 mL of ethanol/water (95/5) was stirred at: 80° C. for 5 h, filtered and evaporated. The residue was purified on preparative TLC (10percent[aq.NH4OH/MeOH 1/9]/DCM), 72 mg of the desired product was obtained as an gummy solid. It was converted into hydrochloride salt with 4N HCl/dioxane and delivered for bioassays. Mass Spectrum (NH3-CI): m/z 466.2 (M+1).
  • 20
  • [ 890121-49-0 ]
  • [ 5382-17-2 ]
  • 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid {1-[2-(4-hydroxypiperidin-1-yl)-2-oxoethyl]-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl}amide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With 4-methyl-morpholine; 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride; In ethanol; at 20℃; for 16.0h; Example 28: 5-Chloro-lH-pyrrolo[2,3-c]pyridine-2-carboxylic acid {l-[2-(4-hydroxypiperidin- l-yl)-2-oxoethyl]-2-oxo-l,2,3,4-tetrahydroquinolin-3-yl}amide; DMTMM (83mg, 0.30mmol) was added to a stirred solution of {3-[(5-chloro-lH-pyrrolo[2,3- c]pyridine-2-carbonyl)amino]-2-oxo-3,4-dihydro-2H-quinolin-l-yl}acetic acid (Example 22, lOOmg, 0.25mmol) and <strong>[5382-17-2]4-hydroxypiperidine hydrochloride</strong> (38mg, 0.28mmol) in ethanol (1OmL) and 4- methylmorpholine (30muL, 0.28mmol). The reaction was stirred at rt for 16h. The solvent was removed in vacuo and the residue triturated with H2O affording the title compound as a white solid, m/z (ES+) 482 [M+H]+; RT = 2.97min.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 5382-17-2 ]

Alcohols

Chemical Structure| 5382-16-1

[ 5382-16-1 ]

4-Piperidinol

Similarity: 0.95

Chemical Structure| 106-52-5

[ 106-52-5 ]

1-Methylpiperidin-4-ol

Similarity: 0.88

Chemical Structure| 3518-83-0

[ 3518-83-0 ]

N-Ethyl-4-hydroxypiperidine

Similarity: 0.88

Chemical Structure| 40064-34-4

[ 40064-34-4 ]

Piperidine-4,4-diol hydrochloride

Similarity: 0.85

Chemical Structure| 1185293-84-8

[ 1185293-84-8 ]

3-Methylpiperidin-4-ol hydrochloride

Similarity: 0.85

Related Parent Nucleus of
[ 5382-17-2 ]

Aliphatic Heterocycles

Chemical Structure| 5382-16-1

[ 5382-16-1 ]

4-Piperidinol

Similarity: 0.95

Chemical Structure| 106-52-5

[ 106-52-5 ]

1-Methylpiperidin-4-ol

Similarity: 0.88

Chemical Structure| 3518-83-0

[ 3518-83-0 ]

N-Ethyl-4-hydroxypiperidine

Similarity: 0.88

Chemical Structure| 1185293-84-8

[ 1185293-84-8 ]

3-Methylpiperidin-4-ol hydrochloride

Similarity: 0.85

Chemical Structure| 4045-25-4

[ 4045-25-4 ]

4-Methoxypiperidine hydrochloride

Similarity: 0.85

Piperidines

Chemical Structure| 5382-16-1

[ 5382-16-1 ]

4-Piperidinol

Similarity: 0.95

Chemical Structure| 106-52-5

[ 106-52-5 ]

1-Methylpiperidin-4-ol

Similarity: 0.88

Chemical Structure| 3518-83-0

[ 3518-83-0 ]

N-Ethyl-4-hydroxypiperidine

Similarity: 0.88

Chemical Structure| 1185293-84-8

[ 1185293-84-8 ]

3-Methylpiperidin-4-ol hydrochloride

Similarity: 0.85

Chemical Structure| 4045-25-4

[ 4045-25-4 ]

4-Methoxypiperidine hydrochloride

Similarity: 0.85

; ;